Uncoordinated HLA-D gene expression in a RFXANK-defective patient with MHC class II deficiency

Journal of Immunology

Volumn 166, Issue 9, 2001, Pages 5681-5687

  Lennon Dumenil A M ^a   Barbouche, M R ^a   Vedrenne, J ^a   Prod'Homme, T ^a   Bejaoui M ^a   Ghariani, S ^a   Charron, D ^a   Fellous, M ^a   Dellagi, K ^a   Alcaide Loridan C ^a  

^a CENTRE DE RECHERCHE DES CORDELIERS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HLA D ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ARTICLE; BINDING SITE; CASE REPORT; CELL CULTURE; CLINICAL FEATURE; EXON; FLOW CYTOMETRY; GENE EXPRESSION; GENE MUTATION; GENETIC ANALYSIS; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; INFANT; MALE; OPEN READING FRAME; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0035341115     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.9.5681     Document Type: Article

References (48)

1. MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activation
2. A defect in the regulation of major histocompatibility complex class II gene expression in human HLA-DR negative lymphocytes from patients with a combined immunodeficiency syndrome
3. Major histocompatibility complex class II deficiency: Clinical manifestations, immunologic features, and outcome
4. Class II-antigen-negative patient and mutant B-cell lines represent at least three, and probably four, distinct genetic defects defined by complementation analysis
5. Congenital immunodeficiencies associated with absence of HLA class II antigens on lymphocytes result from distinct mutations in trans-acting factors
6. The regulation of major histocompatibility complex class-II genes: X, Y and other letters of the alphabet
7. A multiplicity of CCAAT box-binding proteins
8. Co-evolution from yeast to mouse: cDNA cloning of the two NFY (CP1/CBF) subunits
9. Recombinant rat CBF-C, the third subunit of CBF/NFY, allows formation of a protein-DNA complex with CBF-A and CBF-B and with yeast HAP2 and HAP3
10. CREB regulates MHC class II expression in a CIITA-dependent manner
11. Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein, RF-X
12. Defective HLA DRA X box binding in the class II transactive transcription factor mutant 6.1.6 and in cells from class II immunodeficient patients
13. A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients
14. RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome, an MHC class II deficiency
15. A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome)
16. RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency
17. Genetic and molecular definition of complementation group D in MHC class II deficiency
18. Mutation of RFXAP, a regulator of MHC class II genes, in primary MHC class II deficiency
19. Novel mutations within the RFX-B gene and partial rescue of MHC and related genes through exogenous class II transactivator in RFX-B-deficient cells
20. Function of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-Y
21. Cooperative binding between factors RFX and X2bp to the X and X2 boxes of MHC class II promoters
22. A functionally essential domain of RFX5 mediates activation of major histocompatibility complex class II promoters by promoting cooperative binding between RFX and NF-Y
23. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome)
24. Class II MHC transcriptional mutants are defective in higher order complex formation
25. Transcriptional scaffold: CIITA interacts with NF-Y, RFX, and CREB to cause stereospecific regulation of the class II major histocompatibility complex promoter
26. Regulation of MHC class II genes: Lessons from a disease
27. Founder effect for a 26-bp deletion in the RFXANK gene in North African MHC class II deficient patients belonging to complementation group B
28. Monoclonal antibodies against HLA-DRw antigens
29. Subsets of human la-like molecules defined by monoclonal antibodies
30. Detection of a novel human class II HLA antigen
31. Distribution of class II DQ antigens on normal and leukemic lymphoid cells
32. Two complementation groups account for most cases in inherited MHC class II deficiency
33. Genetic evidence for a new type of major histocompatibility complex class II combined immunodeficiency characterized by a dyscoordinate regulation of HLA-D α and β chains
34. The RAG cell line defines a new complementation group of MHC class II deficiency
35. Construction of chain- and locus-specific HLA class II DNA probes: Study of HLA-class II transcripts in leukemias: Construction of chain- and locus-specific HLA class II DNA probes
36. The structure and function of the novel MHC class II molecule, HLA-DM
37. Defective MHC class II expression in an MHC class II deficiency patient is caused by a novel deletion of a splice donor site in the MHC class II transactivator gene
38. Isolation of a B-cell-specific promoter for the human class II transactivator
39. Differential expression of MHC class II isotype chains
40. HLA class II expression in human tumor lines
41. Mapping of the interaction site of the defective transcription factor in the class II major histocompatibility complex mutant cell line clone-13 to the divergent X2-box
42. Uncoordinate induction and differential regulation of the HLA class I and class II expression by γ-interferon in differentiating human neuroblastoma cells
43. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients
44. Twin boys with major histocompatibility complex class II deficiency but inducible immune responses
45. Orientation and positional mapping of the subunits of the multicomponent transcription factors RFX and X2BP to the major histocompatibility complex class II transcriptional enhancer
46. Formation of a RFXX2BP-NF-Y multiprotein complex on the conserved regulatory regions of HLA class II genes
47. The ankyrin repeat-containing adaptator protein Tvl-1 is a novel substrate and regulator of Raf-1
48. Associations and interactions between bare lymphocyte syndrome factors